ArticleThe Journal of clinical investigation2025
Targeting LAIR1-mediated immunosuppression adds a new weapon to our immunotherapy arsenal.
Ezri P Perrin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it